0000939767-21-000105.txt : 20211123 0000939767-21-000105.hdr.sgml : 20211123 20211123201155 ACCESSION NUMBER: 0000939767-21-000105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211119 FILED AS OF DATE: 20211123 DATE AS OF CHANGE: 20211123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FELDBAUM CARL B CENTRAL INDEX KEY: 0001326377 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 211440748 MAIL ADDRESS: STREET 1: C/O EXELIXIS INC STREET 2: 170 HARBOR WAY, PO BOX 511 CITY: SOUTH SAN FRISCISCO STATE: CA ZIP: 94083-0511 FORMER NAME: FORMER CONFORMED NAME: Feldbaum Carl B DATE OF NAME CHANGE: 20050506 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_163771629639082.xml FORM 4 X0306 4 2021-11-19 0 0000939767 EXELIXIS, INC. EXEL 0001326377 FELDBAUM CARL B C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 1 0 0 0 Common Stock 2021-11-19 4 M 0 20000 3.13 A 28521 D Common Stock 2021-11-19 4 S 0 20000 17.62 D 8521 D Option (right to buy) 3.13 2021-11-19 4 M 0 20000 0 D 2015-05-28 2022-05-27 Common Stock 20000.0 20000 D Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.57 to $17.68. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2021-11-23